iRhythm Holdings (IRTC) Cash from Investing Activities (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Cash from Investing Activities came in at $30.2 million in Q1 2026, up 179.22% year-on-year from $10.8 million in Q1 2025, and up 161.92% on a QoQ basis from -$48.8 million in Q4 2025.
iRhythm Holdings (IRTC) Cash from Investing Activities (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Cash from Investing Activities data on file, last reported at $30.2 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 179.22% year-over-year to $30.2 million in Q1 2026; TTM through Mar 2026 was -$208.7 million, a 3.77% decrease from a year earlier, with the FY2025 full-year figure at -$277.1 million, down 125.28% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $30.2 million, up from -$48.8 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for IRTC reached as high as $40.0 million in Q1 2024 and fell as low as -$122.2 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$24.9 million across 5 years, with a median of -$8.5 million in 2022.
- Across the five-year window, Cash from Investing Activities surged 2190.26% in 2023 and plunged 8825.64% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$8.1 million in 2022, then jumped by 117.25% to $1.4 million in 2023, then plunged by 8825.64% to -$122.2 million in 2024, then surged by 60.05% to -$48.8 million in 2025, then surged by 161.92% to $30.2 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $30.2 million in Q1 2026, -$48.8 million in Q4 2025, and -$89.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | iRhythm Holdings | 3.65 Bn | 3.10 Bn | 141.35 Mn | 30.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.22 Mn |
| Mar 31, 2026 | 30.22 Mn |
| Dec 31, 2025 | -48.80 Mn |
| Dec 31, 2025 | -48.80 Mn |
| Sep 30, 2025 | -89.20 Mn |
| Sep 30, 2025 | -89.20 Mn |
| Jun 30, 2025 | -100.92 Mn |
| Jun 30, 2025 | -100.92 Mn |
| Mar 31, 2025 | -38.14 Mn |
| Mar 31, 2025 | -38.14 Mn |
| Dec 31, 2024 | -122.16 Mn |
| Dec 31, 2024 | -122.16 Mn |
| Sep 30, 2024 | -55.33 Mn |
| Sep 30, 2024 | -55.33 Mn |
| Jun 30, 2024 | 14.51 Mn |
| Jun 30, 2024 | 14.51 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |